HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linus Jönsson Selected Research

Patient Care

1/2017Erratum to: The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care.
11/2016The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care.
7/2011Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants.
2/2011Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease.
6/2010Willingness-to-pay for reductions in care need: estimating the value of informal care in Alzheimer's disease.
3/2010The worldwide societal costs of dementia: Estimates for 2009.
7/2007Time use and costs of institutionalised elderly persons with or without dementia: results from the Nordanstig cohort in the Kungsholmen Project--a population based study in Sweden.
4/2007An estimate of the total worldwide societal costs of dementia in 2005.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Linus Jönsson Research Topics

Disease

12Dementia (Dementias)
01/2021 - 01/2003
10Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2003
3Cognitive Dysfunction
01/2021 - 06/2005
3Disease Progression
10/2019 - 09/2002
2Schizophrenia (Dementia Praecox)
12/2021 - 01/2020
2Esophageal Atresia
03/2019 - 06/2014
2Type 2 Diabetes Mellitus (MODY)
05/2006 - 09/2005
2Hypoglycemia (Reactive Hypoglycemia)
05/2006 - 09/2005
2Osteoporosis
10/2003 - 01/2003
1Multiple System Atrophy
01/2022
1Psychotic Disorders (Schizoaffective Disorder)
01/2020
1Stroke (Strokes)
01/2020
1Treatment-Resistant Schizophrenia
01/2019
1Birth Weight (Birth Weights)
10/2018
1Renal Cell Carcinoma (Grawitz Tumor)
01/2014
1Breast Neoplasms (Breast Cancer)
05/2007
1Cardiovascular Diseases (Cardiovascular Disease)
01/2006
1Diabetes Mellitus
01/2006
1Heart Diseases (Heart Disease)
12/2005
1Asthma (Bronchial Asthma)
05/2004
1Wrist Fractures
01/2003
1Chronic Progressive Multiple Sclerosis
01/2002

Drug/Important Bio-Agent (IBA)

3Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2021 - 01/2003
2Antipsychotic Agents (Antipsychotics)IBA
01/2020 - 01/2019
2Hypoglycemic Agents (Hypoglycemics)IBA
05/2006 - 09/2005
2Alendronate (Alendronate Sodium)FDA LinkGeneric
10/2003 - 01/2003
1rasagiline (Azilect)FDA Link
01/2022
1Pharmaceutical PreparationsIBA
12/2021
1Galantamine (Galanthamine)FDA LinkGeneric
01/2021
1Polytetrafluoroethylene (Teflon)FDA Link
01/2020
1SiliconesIBA
06/2014
1Axitinib (AG 013736)IBA
01/2014
1Sorafenib (BAY 43-9006)FDA Link
01/2014
1Donepezil (Aricept)FDA LinkGeneric
10/2012
1exemestane (Aromasin)FDA Link
05/2007
1TamoxifenFDA LinkGeneric
05/2007
1CholesterolIBA
01/2006
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2006
1oxidized low density lipoproteinIBA
01/2006
1LipidsIBA
12/2005
1Insulin (Novolin)FDA Link
09/2005
1Memantine (Namenda)FDA Link
06/2005
1Diphosphonates (Bisphosphonates)IBA
01/2003
1ametantrone (HAQ)IBA
09/2002
1Interferon beta-1b (Betaseron)FDA Link
01/2002

Therapy/Procedure

8Patient Care
01/2017 - 04/2007
7Therapeutics
10/2019 - 01/2003
4Activities of Daily Living (ADL)
07/2011 - 07/2007
1Stroke Rehabilitation
01/2020
1Institutionalization (Institutionalized Persons)
01/2020
1Operative Surgical Procedures
03/2019
1Gastrostomy
10/2018
1Glycemic Control
09/2005
1Length of Stay
05/2004